The cervical cancer drugs market is driven by the increasing prevalence of cervical cancer, unprotected sex, and an increase in the incidence of HIV among women, and poor knowledge about cervical cancer diagnosis, prevention, and treatment. Additionally, the cervical cancersource https://www.openpr.com/news/2337565/cervical-cancer-drugs-market-has-its-sights-set-on